Keywords: eisai, acquires, rights, teikoku, antiulcerant, says, acquired

Eisai acquires rights to Teikoku's antiulcerant

Article | 29 August 2000

Print This

Eisai says it has acquired exclusive rights to conduct clinical trialsand market worldwide Teikoku Chemical's TKS1044, which the latter says ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in